Multicentre Radial Artery Patency Study: Results of Patency Beyond 5 Years After Coronary Artery Bypass Surgery
RAPS - 5 years
1 other identifier
interventional
269
2 countries
13
Brief Summary
Bypass surgery is often required to treat severe coronary heart disease. Either arteries or veins can be used as bypass grafts. We wish to compare the long-term durability of the saphenous vein from the leg to that of the radial artery from the fore-arm when used as bypass grafts. We are examining how many of these grafts are still functioning beyond 5 years after bypass surgery by performing a coronary angiogram. After 1-year, we found that radial arteries were more likely to be functioning than saphenous veins. We hypothesize that radial arteries will continue to be superior beyond 5 years.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for phase_3 coronary-artery-disease
Started Jul 2002
Longer than P75 for phase_3 coronary-artery-disease
13 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2002
CompletedFirst Submitted
Initial submission to the registry
September 10, 2005
CompletedFirst Posted
Study publicly available on registry
September 16, 2005
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2010
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2010
CompletedJune 5, 2013
June 1, 2013
8.2 years
September 10, 2005
June 4, 2013
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
The primary endpoint will be the proportion of grafts which are functionally occluded (TIMI flow 0, 1, or 2).
Beyond 5 years after bypass urgery
Secondary Outcomes (4)
a) the proportion of occluded study grafts (TIMI 0)
Beyond 5 years after bypass urgery
b) the proportion of functionally occluded grafts where proximal stenosis of native vessel is <90% vs >90%
Beyond 5 years after bypass urgery
c) the proportion of completely occluded grafts where proximal stenosis of native vessel is <90% vs >90%
Beyond 5 years after bypass urgery
d) proportion of study grafts with string sign
Beyond 5 years after bypass urgery
Study Arms (1)
Surgical Conduit
EXPERIMENTALThe surgical arm will be composed of the experimental arm (the use of the radial artery) versus an active comparator (the use of the saphenous vein graft).
Interventions
Each patient will receive both study grafts (Radial artery and Study Saphenous vein graft). The within-patient randomization scheme will dictate whether the radial goes to the right or circumflex territory. The saphenous vein graft will go to the opposing territory.
Eligibility Criteria
You may qualify if:
- The patient population consists of patients who were enroled into the original Multicentre Radial Artery Patency Study between November 1996 and January 2001. These included patients undergoing isolated coronary artery bypass surgery less than 80 years of age with 3 vessel coronary disease and left ventricular ejection fraction greater than 35%.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (13)
University of Alberta
Edmonton, Alberta, T6G 2B7, Canada
Manitoba Health Sciences Centre
Winnipeg, Manitoba, R3A 1R9, Canada
London Health Sciences Centre - UC
London, Ontario, N6A 5A5, Canada
London Health Sciences Centre - VC
London, Ontario, N6B1B1, Canada
Ottawa Heart Institute
Ottawa, Ontario, K1Y 4W7, Canada
Sunnybrook and Women's College HSC
Toronto, Ontario, M4N3M5, Canada
St. Michael's Hospital
Toronto, Ontario, M5B1W8, Canada
Toronto General Hospital
Toronto, Ontario, M5G2C4, Canada
Vancouver General Hospital
Vancouver, Ontario, V5Z1C6, Canada
Laval Hospital
Laval, Quebec, G1V4G5, Canada
Montreal Heart Institute
Montreal, Quebec, H1T 1C8, Canada
Montreal Jewish General Hospital
Montreal, Quebec, H3T 1E2, Canada
Waikato Hospital
Hamilton, New Zealand
Related Publications (6)
Fremes SE. Multicenter radial artery patency study (RAPS). Study design. Control Clin Trials. 2000 Aug;21(4):397-413. doi: 10.1016/s0197-2456(00)00059-3.
PMID: 10913815BACKGROUNDDesai ND, Cohen EA, Naylor CD, Fremes SE; Radial Artery Patency Study Investigators. A randomized comparison of radial-artery and saphenous-vein coronary bypass grafts. N Engl J Med. 2004 Nov 25;351(22):2302-9. doi: 10.1056/NEJMoa040982.
PMID: 15564545RESULTDeb S, Cohen EA, Singh SK, Une D, Laupacis A, Fremes SE; RAPS Investigators. Radial artery and saphenous vein patency more than 5 years after coronary artery bypass surgery: results from RAPS (Radial Artery Patency Study). J Am Coll Cardiol. 2012 Jul 3;60(1):28-35. doi: 10.1016/j.jacc.2012.03.037.
PMID: 22742399RESULTTam DY, Deb S, Nguyen B, Ko DT, Karkhanis R, Moussa F, Fremes J, Cohen EA, Radhakrishnan S, Fremes SE. The radial artery is protective in women and men following coronary artery bypass grafting-a substudy of the radial artery patency study. Ann Cardiothorac Surg. 2018 Jul;7(4):492-499. doi: 10.21037/acs.2018.05.19.
PMID: 30094213DERIVEDDeb S, Singh SK, Moussa F, Tsubota H, Une D, Kiss A, Tomlinson G, Afshar M, Sless R, Cohen EA, Radhakrishnan S, Dubbin J, Schwartz L, Fremes SE; Radial Artery Patency Study Investigators. The long-term impact of diabetes on graft patency after coronary artery bypass grafting surgery: a substudy of the multicenter Radial Artery Patency Study. J Thorac Cardiovasc Surg. 2014 Oct;148(4):1246-53; discussion 1253. doi: 10.1016/j.jtcvs.2014.06.057. Epub 2014 Jul 17.
PMID: 25109754DERIVEDYanagawa B, Algarni KD, Singh SK, Deb S, Vincent J, Elituv R, Desai ND, Rajamani K, McManus BM, Liu PP, Cohen EA, Radhakrishnan S, Dubbin JD, Schwartz L, Fremes SE. Clinical, biochemical, and genetic predictors of coronary artery bypass graft failure. J Thorac Cardiovasc Surg. 2014 Aug;148(2):515-520.e2. doi: 10.1016/j.jtcvs.2013.10.011. Epub 2013 Dec 9.
PMID: 24332189DERIVED
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Stephen E Fremes, MD
Sunnybrook Health Sciences Centre
Study Design
- Study Type
- interventional
- Phase
- phase 3
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Head, Division of Cardiac and Vascular Surgery and Dr. Bernard S. Goldman Chair in Cardiovascular Surgery
Study Record Dates
First Submitted
September 10, 2005
First Posted
September 16, 2005
Study Start
July 1, 2002
Primary Completion
September 1, 2010
Study Completion
October 1, 2010
Last Updated
June 5, 2013
Record last verified: 2013-06